InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Explore the complete record of transactions filed by Deborah Waterhouse, Chief Executive Officer. Officer active across 1 company, notably GSK plc. Cumulatively, 1 disclosures have been published. History available since 12 May 2026. The latest transaction was filed on 12 May 2026 (Purchase). Regulator: RNS (LSE). The full history is free.
Declarations1 total
●
12 shares@ £18.7780.0000% mcap100.0% of flowLondon Stock Exchange (XLON)RNS:9569357-6
Ideal exit: 6 Feb 2027 (T+270)
1 of 1 declaration
About Deborah Waterhouse
Deborah Waterhouse is the CEO of ViiV Healthcare and President of Global Health at GSK. In these roles, she oversees the strategy and operations of the company, ensuring its growth and development in the healthcare sector. Her leadership is crucial in achieving the organization's strategic objectives.
